Luciana Molinero to Survival Rate
This is a "connection" page, showing publications Luciana Molinero has written about Survival Rate.
Connection Strength
0.072
-
Digital Versus Manual PD-L1 Scoring in Advanced NSCLC From the IMpower110 and IMpower150 Trials. J Thorac Oncol. 2025 Dec; 20(12):1778-1790.
Score: 0.043
-
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2020 01; 21(1):44-59.
Score: 0.029